Trial Profile
A second phase III trial of AXS-02 for complex regional pain syndrome.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 15 Jan 2016
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Complex regional pain syndromes
- Focus Therapeutic Use
- 15 Jan 2016 New trial record